Edition:
India

Hikma Pharmaceuticals PLC (HIK.L)

HIK.L on London Stock Exchange

2,228.00GBp
4:10pm IST
Change (% chg)

9.00 (+0.41%)
Prev Close
2,219.00
Open
2,222.00
Day's High
2,235.00
Day's Low
2,207.00
Volume
204,414
Avg. Vol
1,271,271
52-wk High
2,670.00
52-wk Low
1,596.00

Select another date:

Thu, Jun 25 2020

BRIEF-Hikma Pharmaceuticals Says Jochen Gann Has Resigned His Directorship Of Co

* HIKMA - JOCHEN GANN HAS RESIGNED HIS DIRECTORSHIP OF HIKMA WITH IMMEDIATE EFFECT

UPDATE 2-S.Africa's Aspen could supply 10 mln dexamethasone pills in COVID-19 crisis

* WHO says it is analysing results for COVID-19 guidance (Adds details from Hikma, WHO statement)

Deals of the day-Mergers and acquisitions

June 22 The following bids, mergers, acquisitions and disposals were reported by 2000 GMT on Monday:

Hikma's major investor to exit nearly 1 bln pound stake in drugmaker

Boehringer Ingelheim, a major shareholder in Hikma Pharmaceuticals , is exiting the London-listed drugmaker by selling most of its nearly one billion pound stake to institutional investors and the rest back to the company, Hikma said on Monday.

UPDATE 1-Hikma's major investor to exit nearly 1 bln pound stake in drugmaker

June 22 Boehringer Ingelheim, a major shareholder in Hikma Pharmaceuticals, is exiting the London-listed drugmaker by selling most of its nearly one billion pound stake to institutional investors and the rest back to the company, Hikma said on Monday.

Germany's pharma firm Boehringer to offload stake in drugmaker Hikma

June 22 Hikma Pharmaceuticals said on Monday investor Boehringer Ingelheim would sell up to 28 million shares in the London-listed drugmaker, or shares worth about 700 million pounds ($871.43 million), according to a bookrunner for the deal.

BRIEF-Boehringer Ingelheim Intends To Sell Up To About 28 Mln Shares In Hikma

* J.P. MORGAN SEC PLC HIKMA PHARMACEUTICAL - PROPOSED PLACING IN HIKMA PHARMACEUTICALS PLC

BRIEF-Sun Pharma, Hikma Sign Exclusive Licensing Deal For Ilumya For MENA Region

* SUN PHARMA AND HIKMA ENTER INTO EXCLUSIVE LICENSING AGREEMENT FOR ILUMYA FOR MIDDLE EAST & NORTH AFRICA REGIONS

BRIEF-Premier Partners With Hikma Pharmaceuticals To Supply Amiodarone And Sterile Water To Healthcare Providers

* PREMIER INC - PARTNERED WITH HIKMA PHARMACEUTICALS TO SUPPLY AMIODARONE AND STERILE WATER TO HEALTHCARE PROVIDERS Source text for Eikon: Further company coverage:

BRIEF-Hikma Pharmaceutical U.S. Subsidiary Receives FDA Approval For Generic Vascepa

* SUBSIDIARY HIKMA PHARMACEUTICALS USA RECEIVED APPROVAL FROM U.S. FDA FOR ITS ICOSAPENT ETHYL CAPSULES, 1 GM, GENERIC EQUIVALENT TO VASCEPA Source text for Eikon: Further company coverage:

Select another date: